Figure 3.
Kaplan-Meier curves for the primary end point comparing the 12- and 3-month edoxaban groups in the subgroups stratified by D-dimer levels at 3 months. (A) Low D-dimer subgroup. (B) High D-dimer subgroup. The primary end point is a composite of symptomatic recurrent VTE or VTE-related death.